Loading clinical trials...
Loading clinical trials...
Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study
Conditions
Interventions
Psilocybin
Locations
2
United States
Enact Research Collaborative (40 Temple St, 4th Floor)
New Haven, Connecticut, United States
Yale Program for Psychedelic Research
New Haven, Connecticut, United States
Start Date
July 20, 2023
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2027
Last Updated
February 13, 2026
NCT06647589
NCT04480918
NCT05623306
NCT07245134
NCT07232823
NCT04131829
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions